PriceTargets.com logo

OTCMKTS:UDHCF - UDG Healthcare Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$14.79 As of 11/29/2021 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for UDHCF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New UDG Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UDHCF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UDHCF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for UDG Healthcare in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $14.79.

This chart shows the closing price for UDHCF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in UDG Healthcare. This rating has held steady since May 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
2/17/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
5/18/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
8/16/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/14/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
2/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
5/13/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/11/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/13/2021Jefferies Financial GroupUpgradeUnderperform ➝ Hold
5/13/2021Berenberg BankDowngradeBuy ➝ Hold
5/6/2021BarclaysReiterated RatingOverweight
11/11/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform
11/9/2020Jefferies Financial GroupDowngradeHold ➝ Underperform
10/2/2020Stifel NicolausDowngradeBuy ➝ Hold
3/20/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform
4/4/2019BarclaysUpgradeEqual Weight ➝ Overweight
(Data available from 8/12/2017 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/14/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/13/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/15/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/14/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/14/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/13/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/13/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/12/2022

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
UDG Healthcare logo
UDG Healthcare Plc engages in the supply and distribution of pharmaceutical and medical products. It operates through the following segments: Ashfield, Sharp, and Aquilant. The Ashfield segment provides commercialization services for the pharmaceutical and healthcare industry. The Sharp segment offers contract packaging and clinical trial packaging services. The Aquilant segment involves. outsourced sales, marketing, distribution, and engineering services to the medical and scientific sectors. The company was founded in 1948 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $14.79
Low: $14.79
High: $14.79

50 Day Range

MA: $14.79
Low: $14.79
High: $14.79

52 Week Range

Now: $14.79
Low: $10.86
High: $14.79

Volume

N/A

Average Volume

16,957 shs

Market Capitalization

$3.68 billion

P/E Ratio

N/A

Dividend Yield

1.28%

Beta

0.62

Frequently Asked Questions

What sell-side analysts currently cover shares of UDG Healthcare?

The following Wall Street analysts have issued research reports on UDG Healthcare in the last year:
View the latest analyst ratings for UDHCF.

What is the current price target for UDG Healthcare?

0 Wall Street analysts have set twelve-month price targets for UDG Healthcare in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for UDG Healthcare in the next year.
View the latest price targets for UDHCF.

What is the current consensus analyst rating for UDG Healthcare?

UDG Healthcare currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for UDHCF.

What other companies compete with UDG Healthcare?

Other companies that are similar to UDG Healthcare include Aspen Pharmacare, GN Store Nord A/S, Nihon Kohden, Orion Oyj and Aurora Cannabis. Learn More about companies similar to UDG Healthcare.

How do I contact UDG Healthcare's investor relations team?

UDG Healthcare's physical mailing address is 20 Riverwalk Citywest Business Campus Citywest, Dublin L2, 24. The company's listed phone number is (531) 468-9000 and its investor relations email address is [email protected] The official website for UDG Healthcare is www.udghealthcare.com. Learn More about contacing UDG Healthcare investor relations.